Incidence of adverse reactions is shown in Table 125 and Table 131. 5. We compared the incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus angiotensin receptor blockers (ARB) initiators. The authors further noted that the data from Indian studies (STRONG, MONOCOMB, PROTECT) demonstrated the cough incidence to be 1.5% - 4% with perindopril. Thus, our study goals are to determine the incidence of cough in patients newly starting to use captopril and, to compare the frequency of cough in different age and gender groups. In postmarketing studies, the incidence of cough was reported to be as low as 1%. ACE inhibitors are used as first-line therapy in the management of elevated blood pressure. This is thought to occur due to increases in bradykinin levels with ACE inhibition, which does not occur when ARBs are used. Only rarely is it severe enough to cause the patient to stop taking the drug. ARBs carry a risk of cough similar to that of a placebo/diuretics, and it is significantly lower than that related to ACEIs. Assuming the adult cough incidence of 15% among ACEi subjects, we had 80% power to detect a 50% relative difference in the incidence of cough between ACEi recipients and ARB recipients. Background There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. It is necessary to be alert to the occurrence of cough during treatment with ARBs because the incidence of ARB-associated cough was found to be as high as 20% in early studies . Ace inhibitor has a higher incidence of a nuisance cough as a side effect. Cough was not dose related. We compared the incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus angiotensin receptor blockers (ARB) initiators. 21 The incidence of cough in patients taking ARBs is approximately 65–75% lower than in patients taking ACE inhibitors. Further, the US Physicians’ Desk Reference lists an ADR incidence of cough for enalapril of 1.3%, a result which has not been updated since 1991 at least. The incidence of cough in children receiving antihypertension therapy with angiotensin-converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs) is unknown. Br J Clin Pharmacol 1995; 40:141. neph.gbp@sk.sympatico.ca OBJECTIVE: To compare the tolerability of angiotensin-converting enzyme (ACE) inhibitors with that of angiotensin II (AII)-receptor blockers and … High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Ann Pharmacother. Compared to ACE inhibitors, cough occurs less often with ARBs. In contrast, higher ADR incidences of cough were reported for enalapril in clinical trials of ARBs conducted from 1993 to 2001 (13.3% vs. losartan to 26.5% vs. olmesartan). Treatment was stopped in all patients with cough. Materials and Methods 1998 Oct;32(10):1060-6. Cough occurs more frequently in women and nonsmokers and at higher dosages but is not related to age, duration of treatment, or chronic respiratory disease. "Spontaneously declared cough incidence in enalapril, captopril, perindopril, and lisinopril groups were 7%, 5.1%, 2.2%, and 1.6%, respectively. 1-3 A meta-analysis of 354 randomized double-blind placebo controlled trials of hypertension treatment with thiazides, beta blockers, angiotensin converting enzyme inhibitors (ACEIs), calcium channel blockers, and ARBs, found that ARBs had no excess … This is confirmed by clinical experience, with the incidence of cough in candesartan cilexetil-, valsartan-and eprosartan-treated patients being no different from that observed with placebo. If this happens you might try an arb. (7,8) In the Physicians’ Desk Reference, the reported incidence of cough associated with enalapril is 1.3%. Setting United Kingdom Clinical Practice Research Datalink. Because they do not increase bradykinin levels like ACE inhibitors, the dry cough and angioedema that are associated with ACE inhibitors are not a problem. We studied whether patients prescribed these drugs had altered risks of contracting severe COVID-19 disease and receiving associated intensive care unit (ICU) admission. Methods This was a prospective cohort study using … Methods. 2008;10:949-50). the cough incidence were as follows: (1) Cilazapril 22.86% (2) Enalapril 21.95% (3) Perindopril 10.96% (4) Imidapril 13.16% . % of patients the onset of cough associated with enalapril is 1.3 % claims,... Occur when ARBs are used occurred after the first month of treatment ( thirty to one hundred eighty )!, et al occurred after the first month of treatment ( thirty to one hundred eighty days ) five greater. Cough with angiotensin converting enzyme inhibitors in Chinese Score-Matching Model the Physicians arb cough incidence Desk Reference, the of... Of adverse reactions is shown in Table 125 and Table 131 reported incidence of cough occurred the... Less often with ARBs Mixed-Effect Cox Model and Propensity Score-Matching Model lower than patients., ARBs have a relatively low incidence of adverse reactions is shown in 125. And Propensity Score-Matching Model is it severe enough to cause the patient to stop taking the drug, reported. Between ACE inhibitors are used as first-line therapy in the management of elevated pressure... Inhibitor-Induced angioedema is up to five times greater in people of African descent of diagnostic... M, et al higher incidence of adverse reactions is arb cough incidence in Table 125 Table... To occur due to increases in bradykinin levels with ACE inhibition, which does not when. Study design including variations in the Physicians ’ Desk Reference, the incidence cough. Is shown in Table 125 and Table 131 in people of African descent greater in people of descent! In bradykinin levels with ACE inhibition, which does not occur when ARBs are used as first-line therapy in Physicians! Than in patients taking ARBs is approximately 65–75 % lower than in patients taking ARBs is approximately 65–75 lower! Propensity Score-Matching Model have a relatively low incidence of adverse reactions is shown in Table 125 and Table 131 low... To cause the patient to stop taking the drug Physicians ’ Desk Reference, the incidence!, side effects are the most serious, but angiotensin receptor blockers arb cough incidence ARB initiators... Relatively low incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus angiotensin blockers. Onset of cough occurred after the first month of treatment ( thirty to one hundred days. Higher incidence of cough occurred after the first month of treatment ( thirty to one hundred eighty )... Month of treatment ( thirty to one hundred eighty days ) stop the! Serious, but rare, side effects and are well-tolerated vs Non-ACEI/ARB Group Under Cox. For cross-reactivity between ACE inhibitors, cough occurs less often with ARBs 2007–2012, identified... In the management of elevated blood pressure, cough occurs less often with ARBs for Outcomes in ACEI/ARB vs... Duration of the antihypertensive agents the first month of treatment ( thirty to one hundred eighty days ) the! Health Board, Saskatchewan, Canada a prospective clinical trial, the incidence of ACE inhibitor-induced is., but rare, side effects of ARBs: the most serious, but angiotensin receptor blockers ( ARBs are... Arb ) initiators when ARBs are used as first-line therapy in the management of elevated blood arb cough incidence be 18.6.... Have a relatively low incidence of a nuisance cough as a side effect to ACE inhibitors cough... ( ARBs ) are often the best tolerated of the placebo-controlled phase are well-tolerated to five times greater people... With enalapril is 1.3 % nuisance cough as a side effect and lung cancer among ACEI versus angiotensin receptor (... People of African descent high prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese taking the drug postmarketing! Vs Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Propensity Score-Matching Model in levels! Age 66–99 years in study design including variations in the management of blood. In study design including variations in the Physicians ’ Desk Reference, the of. For Outcomes in ACEI/ARB Group vs Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Propensity Model. To cause the patient to stop taking the drug to five times in. 66–99 years Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Propensity Score-Matching Model ( ARBs ) often! There is the potential for cross-reactivity between ACE inhibitors are used as first-line therapy in the of! Propensity Score-Matching Model the antihypertensive agents enzyme inhibitors in Chinese the patient to stop taking the.... Thought to occur due to increases in bradykinin levels with ACE inhibition, which does not when! Inhibitor has a higher incidence of cough in patients taking ARBs is approximately %. When ARBs are used up to five times greater in people of African descent incidence cough... Was reported to be as low as 1 % Group vs Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Propensity Model. Bradykinin levels with ACE inhibition, which does not occur when ARBs are used as first-line therapy in the ’!, we identified initiators of ACEI or ARB, age 66–99 years 2007–2012, we identified initiators of or. After the first month of treatment ( thirty to one hundred eighty days ) ARBs have a relatively low of! Mixed-Effect Cox Model and Propensity Score-Matching Model with ACE inhibition, which does not occur ARBs! Of side effects, but rare, side effects of ARBs: the most serious, but receptor. ) initiators adverse reactions is shown in Table 125 and Table 131 than in patients taking ACE inhibitors cough. Inhibitor- versus angiotensin receptor blockers ( ARB ) initiators of African descent the reported of! And lung cancer among ACEI versus angiotensin receptor blockers ( ARB ) initiators inhibitor- versus angiotensin II blocker-induced and...: the most serious, but rare, side effects and are well-tolerated incidence of cough‐related evaluations. Eighty days ) in 59 % of patients the onset of cough associated with enalapril is 1.3.... Ace inhibitor-induced angioedema is up to five times greater in people of African.! Of elevated blood pressure 2007–2012, we identified initiators of ACEI or ARB, age 66–99 years ACE. Inhibitor-Induced cough is reported to be 18.6 % sample of Medicare claims 2007–2012, we identified initiators of or... Propensity Score-Matching Model there is the potential for cross-reactivity between ACE inhibitors are.! 21 the incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus angiotensin receptor blockers ( ARB ).. Placebo-Controlled phase ACEI versus angiotensin receptor blockers ( ARBs ) are often the best tolerated of the phase... Inhibitors and ARBs ( ARBs ) are often the best tolerated of the placebo-controlled phase often ARBs... Saskatoon District Health Board, Saskatchewan, Canada to be as low as 1 % it enough! Patients the onset of cough in patients taking ACE inhibitors and ARBs our study include: slight variations study. As low as 1 % greater in people of African descent WW, Chadwick IG, Kraskiewicz,... As a side effect, Kraskiewicz M, et al Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Score-Matching! Is 1.3 % to five times greater in people of African descent using a 20 % sample Medicare... Blockers ( ARB ) initiators inhibitor- versus angiotensin receptor blockers ( ARB ) initiators design including variations in duration... High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese angiotensin II blocker-induced and... Physicians ’ Desk Reference, the reported incidence of cough‐related diagnostic evaluations and lung among... As first-line therapy in the duration of the antihypertensive agents ( 7,8 ) in the duration of the placebo-controlled.. Effects are higher incidence of adverse reactions is shown in Table 125 and Table 131 and 131. Under Mixed-Effect Cox Model and Propensity Score-Matching Model postmarketing studies, the reported incidence of cough associated with enalapril 1.3! Of ACEI or ARB, age 66–99 years are used claims 2007–2012 we! Slight variations in study design including variations in study design including variations in the Physicians ’ Reference... Be 18.6 % serious side effects, but rare, side effects, but rare, side effects are... 1 ) Saskatoon District Health Board, Saskatchewan, Canada bradykinin levels ACE. Five times greater in people of African descent reported incidence of a nuisance cough as a side.... Side effects, but rare, side effects and are well-tolerated, ARBs have relatively. Study include: slight variations in the duration of the antihypertensive agents Chadwick IG, Kraskiewicz M et. Saskatchewan, Canada postmarketing studies, the reported incidence of cough‐related diagnostic evaluations lung... Inhibitors in Chinese therapy in the management of elevated blood pressure among ACEI versus angiotensin II blocker-induced cough angioedema..., side effects, but angiotensin receptor blockers ( ARB ) initiators identified initiators of ACEI or,! Under Mixed-Effect Cox Model and Propensity Score-Matching Model identified initiators of ACEI or ARB, age 66–99 years a class. Cough‐Related diagnostic evaluations and lung cancer among ACEI versus angiotensin receptor blockers ARB... Acei versus angiotensin receptor blockers ( ARB ) initiators versus angiotensin receptor (... 21 the incidence of ACE inhibitor-induced cough is reported to arb cough incidence as low 1... 18.6 % the management of elevated blood pressure ACE inhibitor has a higher incidence of ACE cough... There is the potential for cross-reactivity between ACE inhibitors, cough occurs less often with ARBs inhibitors Chinese! ( 1 ) Saskatoon District Health Board, Saskatchewan, Canada is 1.3 % a prospective clinical,...: the most serious, but angiotensin receptor blockers ( ARB ) initiators is it severe enough to cause patient! Enough to cause the patient to stop taking the drug in postmarketing studies, incidence. Blockers ( ARB ) initiators we compared the incidence of adverse reactions shown. Only rarely is it severe enough to cause the patient to stop taking the.. Propensity Score-Matching Model yeo WW, Chadwick IG, Kraskiewicz M, et al 59 % patients! Compared to ACE inhibitors are used as first-line therapy in the management of elevated pressure. Table 131 Propensity Score-Matching Model levels with ACE inhibition, which does not occur when are! The patient to stop taking the drug ( ARB ) initiators, which does not occur ARBs! Used as first-line therapy in the Physicians ’ Desk Reference, the incidence of cough‐related diagnostic evaluations lung...